Akebia Therapeutics, Inc.

AKBA · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.4B · 194 employees
253
SEC Filings
$0.9157
Close 2026-09-18
194
Employees

Business Summary

Akebia Therapeutics is a fully integrated biopharmaceutical company focused on kidney disease. It markets two commercial products: Vafseo (vadadustat), an oral HIF-PH inhibitor approved in March 2024 for anemia due to CKD in dialysis patients, and Auryxia (ferric citrate), approved for serum phosphorus control in DD-CKD and iron deficiency anemia in NDD-CKD. Its pipeline includes praliciguat for FSGS, AKB-097 for complement-mediated rare kidney diseases, and early-stage HIF molecules AKB-9090 and AKB-10108.

Latest Stock Quote

AKBA 2026-09-18 $0.9157 O:$0.89 H:$0.9266 L:$0.88 Vol:7.4M VWAP:$0.9076
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-08-08

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001517022-26-000020EDGAR155K words
2025-03-132024-12-310001628280-25-012470EDGAR143K words
2024-03-142023-12-310001628280-24-011270EDGAR143K words
2023-03-102022-12-310001628280-23-007539EDGAR145K words
2022-03-012021-12-310001628280-22-004522EDGAR—
2021-02-252020-12-310001628280-21-003283EDGAR—
2020-03-122019-12-310001564590-20-010491EDGAR—
2019-03-262018-12-310001564590-19-009340EDGAR—
2018-03-122017-12-310001564590-18-005286EDGAR—
2017-03-062016-12-310001564590-17-003466EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-052026-06-300001517022-26-000051EDGAR89K words
2025-11-102025-09-300001517022-25-000046EDGAR91K words
2025-08-072025-06-300001628280-25-038600EDGAR89K words
2025-05-082025-03-310001628280-25-023460EDGAR84K words
2024-11-072024-09-300001628280-24-045979EDGAR84K words
2024-08-082024-06-300001628280-24-035879EDGAR82K words
2024-05-092024-03-310001628280-24-021945EDGAR79K words
2023-11-082023-09-300001628280-23-037557EDGAR86K words
2023-08-282023-06-300001628280-23-030698EDGAR91K words
2023-05-082023-03-310001628280-23-016258EDGAR77K words
2022-11-032022-09-300001628280-22-028242EDGAR89K words
2022-08-042022-06-300001628280-22-021096EDGAR88K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-050001517022-26-000050EDGAR4K words
2026-04-010001517022-26-000024EDGAR1K words
2026-02-260001517022-26-000019EDGAR4K words
2026-01-300001517022-26-000008EDGAR5K words
2026-01-120001517022-26-000003EDGAR2K words
2025-12-010001517022-25-000051EDGAR2K words
2025-11-170001517022-25-000048EDGAR1K words
2025-11-100001517022-25-000045EDGAR3K words
2025-10-280001517022-25-000040EDGAR1K words
2025-08-070001517022-25-000034EDGAR3K words

253 total filings indexed. 221 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

chronic-kidney-disease-(ckd) dialysis-dependent-ckd-anemia-management non-dialysis-dependent-ckd-iron-deficiency-anemia rare-kidney-diseases end-stage-renal-disease-(esrd) hypoxia-inducible-factor-(hif)-pathway hif-prolyl-hydroxylase-(hif-ph)-inhibition soluble-guanylate-cyclase-(sgc)-stimulation esrd-prospective-payment-system-(pps)-/-esrd-bundle transitional-drug-add-on-payment-adjustment-(tdapa)

Company Identity

CIK0001517022
TickerAKBA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.akebia.com
Listed2014-03-20

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 46bcb46dc16abe60706aa9b9525d929f3d8a1990ad1bade7cca641b134d1e1d4
parent: 6f675ad7b502d6994404d9ea2e58a1aaf680520fd678c177cd23e66601f9d7aa
content hash: 2eaefeea659d1240d54fac6025c7d64b5203cf0e7d56d32f1627effb16c0e7a6
signed: 2026-09-30T12:00:13.689Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up AKBA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on AKBA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/AKBA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.